DEUTSCHE BANK AG\ - BIOLINERX LTD ownership

BIOLINERX LTD's ticker is BLRXXXXX and the CUSIP is 09071M106. A total of 15 filers reported holding BIOLINERX LTD in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BIOLINERX LTD
ValueSharesWeighting
Q4 2018$26,000
-66.7%
61,205
-32.5%
0.00%
Q1 2018$78,000
-73.7%
90,655
-66.8%
0.00%
Q4 2017$297,000
-85.4%
273,095
-85.0%
0.00%
-100.0%
Q3 2017$2,033,000
+353.8%
1,816,701
+242.1%
0.00%
Q2 2017$448,000
+31.0%
531,101
+48.8%
0.00%
Q1 2017$342,000
+74.5%
356,830
+67.0%
0.00%
Q4 2016$196,000
-20.0%
213,6960.0%0.00%
Q3 2016$245,000
+26.3%
213,696
-12.3%
0.00%
Q2 2016$194,000
-21.8%
243,6960.0%0.00%
Q1 2016$248,000
-21.5%
243,6960.0%0.00%
Q4 2015$316,000
-60.6%
243,696
-53.5%
0.00%
-100.0%
Q3 2015$802,000
-53.3%
524,184
-18.9%
0.00%0.0%
Q2 2015$1,718,000
+26.0%
646,1460.0%0.00%0.0%
Q1 2015$1,363,000
+161.1%
646,146
+100.1%
0.00%
Q4 2014$522,000
+76.9%
322,846
+68.3%
0.00%
Q3 2014$295,000
-26.1%
191,8500.0%0.00%
Q2 2014$399,000
-19.7%
191,850
-14.0%
0.00%
Q1 2014$497,000
+22.7%
223,050
+54.6%
0.00%
Q4 2013$405,000
-9.2%
144,250
-29.5%
0.00%
Q3 2013$446,000204,5800.00%
Other shareholders
BIOLINERX LTD shareholders Q4 2013
NameSharesValueWeighting ↓
Senvest Management, LLC 3,543,300$2,835,0000.23%
Opaleye Management Inc. 250,000$223,0000.15%
Benchmark Capital Advisors 44,000$35,0000.03%
MENTA CAPITAL LLC 98,647$79,0000.01%
NEXT Financial Group, Inc 39,500$31,0000.01%
Cutter & CO Brokerage, Inc. 25,000$20,0000.01%
Orbimed Advisors 1,038,600$831,0000.01%
TWO SIGMA SECURITIES, LLC 17,771$14,0000.01%
Alyeska Investment Group, L.P. 611,947$490,0000.01%
A.R.T. Advisors, LLC 25,890$20,0000.00%
View complete list of BIOLINERX LTD shareholders